147 related articles for article (PubMed ID: 37060886)
1. Drug use before and during imprisonment: Drivers of continuation.
Favril L
Int J Drug Policy; 2023 May; 115():104027. PubMed ID: 37060886
[TBL] [Abstract][Full Text] [Related]
2. The Prison and Transition Health (PATH) Cohort Study: Study Protocol and Baseline Characteristics of a Cohort of Men with a History of Injecting Drug Use Leaving Prison in Australia.
Kirwan A; Curtis M; Dietze P; Aitken C; Woods E; Walker S; Kinner S; Ogloff J; Butler T; Stoové M
J Urban Health; 2019 Jun; 96(3):400-410. PubMed ID: 30989484
[TBL] [Abstract][Full Text] [Related]
3. Persistence of drug use during imprisonment: relationship of drug type, recency of use and severity of dependence to use of heroin, cocaine and amphetamine in prison.
Strang J; Gossop M; Heuston J; Green J; Whiteley C; Maden A
Addiction; 2006 Aug; 101(8):1125-32. PubMed ID: 16869842
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with drug use in prison - results from the Norwegian offender mental health and addiction (NorMA) study.
Bukten A; Lund IO; Kinner SA; Rognli EB; Havnes IA; Muller AE; Stavseth MR
Health Justice; 2020 May; 8(1):10. PubMed ID: 32399643
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and correlates of in-prison substance use among incarcerated women in Spain.
Sánchez FC; Fearn N; Vaughn MG
J Ethn Subst Abuse; 2018; 17(3):356-374. PubMed ID: 28166472
[TBL] [Abstract][Full Text] [Related]
6. Factors Affecting Drug Use During Incarceration: A Cross-Sectional Study of Opioid-Dependent Persons from India.
Rao R; Mandal P; Gupta R; Ramshankar P; Mishra A; Ambekar A; Jhanjee S; Dhawan A
J Subst Abuse Treat; 2016 Feb; 61():13-7. PubMed ID: 26470597
[TBL] [Abstract][Full Text] [Related]
7. Predictors of drug use in prison among incarcerated Black men.
Rowell TL; Wu E; Hart CL; Haile R; El-Bassel N
Am J Drug Alcohol Abuse; 2012 Nov; 38(6):593-7. PubMed ID: 22746253
[TBL] [Abstract][Full Text] [Related]
8. Predictors of drug use in prison among women convicted of violent crimes.
Baltieri DA
Crim Behav Ment Health; 2014 Apr; 24(2):113-28. PubMed ID: 24038391
[TBL] [Abstract][Full Text] [Related]
9. Met and unmet prison-based treatment needs for people who are incarcerated with a history of substance use disorder: A nationwide cohort study.
Seid AK; Thylstrup B; Henriksen SH; Hesse M
J Subst Use Addict Treat; 2024 Apr; 159():209264. PubMed ID: 38103836
[TBL] [Abstract][Full Text] [Related]
10. Understanding health and social service accessibility for young people with problematic substance use exiting prison in Australia.
Gilchrist L; Jamieson SK; Zeki R; Ward S; Chang S; Sullivan E
Health Soc Care Community; 2022 Nov; 30(6):e4735-e4744. PubMed ID: 35762623
[TBL] [Abstract][Full Text] [Related]
11. HIV testing among incarcerated people with a history of HIV-related high-risk behaviours in Iran: Findings from three consecutive national bio-behavioural surveys.
Tavakoli F; Parhizgari N; Shokoohi M; Khezri M; Haghdoost AA; Ghasemzadeh I; Bozicevic I; Shahesmaeili A; Nasiri N; Danesh A; Karamouzian M; Sharifi H
BMC Infect Dis; 2022 Dec; 22(1):907. PubMed ID: 36471282
[TBL] [Abstract][Full Text] [Related]
12. The revolving prison door: Factors associated with repeat incarcerations in Spain.
Caravaca Sánchez F; Ignatyev Y; Mundt AP
J Forensic Leg Med; 2020 May; 72():101947. PubMed ID: 32275228
[TBL] [Abstract][Full Text] [Related]
13. Mental health in prison populations. A review--with special emphasis on a study of Danish prisoners on remand.
Andersen HS
Acta Psychiatr Scand Suppl; 2004; (424):5-59. PubMed ID: 15447785
[TBL] [Abstract][Full Text] [Related]
14. The prevalence and comorbidity of mental health and substance use disorders in Scandinavian prisons 2010-2019: a multi-national register study.
Bukten A; Virtanen S; Hesse M; Chang Z; Kvamme TL; Thylstrup B; Tverborgvik T; Skjærvø I; Stavseth MR
BMC Psychiatry; 2024 Feb; 24(1):95. PubMed ID: 38317111
[TBL] [Abstract][Full Text] [Related]
15. Suicide risk in male incarcerated individuals in Spain: clinical, criminological and prison-related correlates.
Vorstenbosch E; Rodríguez-Liron A; Vicens-Pons E; Félez-Nóbrega M; Escuder-Romeva G
BMC Psychol; 2023 Sep; 11(1):282. PubMed ID: 37735464
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and factors associated with alcohol and drug-related disorders in prison: a French national study.
Lukasiewicz M; Falissard B; Michel L; Neveu X; Reynaud M; Gasquet I
Subst Abuse Treat Prev Policy; 2007 Jan; 2():1. PubMed ID: 17204156
[TBL] [Abstract][Full Text] [Related]
17. Discontinuation of opioid agonist treatment following release from prison in a cohort of men who injected drugs prior to imprisonment in Victoria, Australia: A discrete-time survival analysis.
Curtis M; Dietze P; Wilkinson AL; Agius PA; Stewart AC; Cossar RD; Butler T; Walker S; Kirwan A; Winter RJ; Stoové M
Drug Alcohol Depend; 2023 Jan; 242():109730. PubMed ID: 36516552
[TBL] [Abstract][Full Text] [Related]
18. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with psychoactive substance use among a sample of prison inmates in Ilesa, Nigeria.
Amdzaranda PA; Fatoye FO; Oyebanji AO; Ogunro AS; Fatoye GK
Niger Postgrad Med J; 2009 Jun; 16(2):109-14. PubMed ID: 19606190
[TBL] [Abstract][Full Text] [Related]
20. Prisoner exposure to nature: Benefits for wellbeing and citizenship.
Reddon JR; Durante SB
Med Hypotheses; 2019 Feb; 123():13-18. PubMed ID: 30696583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
